Authors


Prof. Mariya Moosajee

Latest:

Landscape of genetic therapies for USH2A-related retinitis pigmentosa

Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.


Michelle Dalton, ELS; Reviewed by Dr Netan Choudhry

Latest:

Treating vitreous opacities with YAG vitreolysis

Study found that YAG laser vitreolysis was less invasive than pars plana vitrectomy for patients with vitreous opacities.


Dr Miorica Bertelli

Latest:

Harnessing the power of light in dry age-related macular degeneration

Photobiomodulation has been demonstrated to improve quality of vision in several patients suffering from dry AMD.


Dr Sandeep Buttan

Latest:

Pilot project aims to overcome inequalities in glaucoma diagnoses

Many low- and middle-income countries lack resources for managing eye health. A pilot project aims to reduce the number of people going blind from untreated glaucoma by raising awareness and increasing engagement with screening and follow-up.


Louise Gagnon

Latest:

Retinal camera unlocks back-of-the-eye secrets

A small study demonstrates that high-resolution imaging with adaptive optics may be a useful method of assessing integrity of the cone mosaic following macular hole repair.



Matthew L. Lorenz, MD

Latest:

Making the diagnosis: Bilateral blurry vision in a 9-year-old boy

The child's changes in vision began at school and worsened over the next day to the point where he could see only outlines and shapes of objects.



Prof. Christina Grupcheva

Latest:

Navigating COVID-19 with ophthalmic patients in the hospital setting

Experience at one ophthalmic practice in Bulgaria demonstrates that new operating procedures, technologies and good management can enable clinics to remain open and operate safely during the COVID-19 pandemic. Ophthalmic training and education should continue to be a priority.


Chirag Jhaveri, MD

Latest:

Clinical Implications of Port Delivery System in Retinal Diseases

Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.


Prof. Robert P Finger

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Lynda Charters; Reviewed by Dr Jason Bacharach

Latest:

Preservative-free latanoprost as effective as BAK-preserved latanoprost

Therapeutic has fewer adverse effects in patients with POAG and OHT, study results show


By Lynda Charters; Reviewed by Carlyn V. Kouwenberg

Latest:

Looking past the eye in paediatric noninfectious uveitis

Disease manifestations in the systemic microcirculation of children


Abdelwahhab Azzawi, MD

Latest:

Understanding Schlemm canal to improve the results of stent surgery

Examining the anatomy and physiology may prevent ineffective stent implantation.


David Hutton; Reviewed by Kamran M Riaz, MD

Latest:

Cutting-edge advances in corneal treatment

Surgeon discusses latest trends for treating cornea


Dr David Lally

Latest:

Sustained-release anti-inflammatory therapy proves valuable in NIU

Long-term treatment helps chronic, vision-threatening disease.


By Lynda Charters; Reviewed by Carolina Picotti, MD

Latest:

Treating anisometropic amblyopia with a dichoptic digital platform

The investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age



Prof. Alastair Denniston

Latest:

Insights into the future of eye care

A UK health data research hub containing vast numbers of fundus and OCT images opens the door to improved screening and diagnoses of eye diseases and even ‘oculomic’ services for systemic health.


Dr Monica Lövestam-Adrian

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Hattie Hayes

Latest:

RetInSight and Heidelberg Engineering partner to implement AI-based geographic atrophy analysis for OCT imaging

In early November, the EU MDR issued a CE mark certification for RetInSight’s AI-based geographic atrophy monitor



James S Talks

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Zeba A. Syed

Latest:

Pearls for management of Pseudomonas scleritis

Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis


Dr Rajen U. Desai

Latest:

New goniotomy device + careful post-op care limits intraoperative bleeding

A new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.


Dr Ramin Tadayoni

Latest:

Worldwide pathological myopia discussed by panel at EURETINA 2021

Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.


Dr Maximilian K. Köppe
Dr Maximilian K. Köppe

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

Newly developed acrylic implant provides option for patients with endothelial dysfunction.


Dr Marguerite B. McDonald

Latest:

New options are on the horizon for presbyopia-correcting drops

For ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.


Bela Parekh, BA, BS; Imane Tarib, MD; and Richard Awdeh, MD

Latest:

Harnessing digital media for enhanced patient engagement and outcomes

Patients who received digital education demonstrated a better understanding of their disease and its management


Dr Sara Giammaria

Latest:

Using pivotal study data to guide glaucoma patient management decisions

Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.

© 2023 MJH Life Sciences

All rights reserved.